BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
BCG
Binah Capital Group, Inc.
There isn't enough reported data to score BCG yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BCG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
BCG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BCG.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
BCG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.3x | $1.10 | — |
| Cheap | 8x | $1.67 | +52% |
| Fair | 15x | $3.25 | +196% |
| Expensive | 76x | $16.04 | +1358% |
Historical ranges are pointers, not guarantees.
BCG has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
BCG Forward outlook
There aren't enough analyst estimates for BCG to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over BCG on earnings, with more consistent year-over-year improvement.
BCG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.21 | +600% |
| Q2 2026 | $0.16 | +$0.28 |
| Q1 2026 | $0.12 | +$0.24 |
| Q4 2025 | $0.09 | +$0.41 |
| Q3 2025 | $0.03 | +$0.33 |
| Q2 2025 | -$0.12 | +$0.09 |
| Q1 2025 | -$0.12 | +$0.05 |
| Q4 2024 | -$0.32 | -900% |
BCG's earnings per share have fallen from their peak: $0.21 over the past year, against $0.36 in mid-2022.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over BCG on profitability, with a higher operating margin.
BCG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.6M | +9.4% |
| Q2 2026 | $46.5M | +12% |
| Q1 2026 | $48.7M | -0.5% |
| Q4 2025 | $50.5M | +13% |
| Q3 2025 | $46.2M | +9.5% |
| Q2 2025 | $41.5M | +2.1% |
| Q1 2025 | $48.9M | +18% |
| Q4 2024 | $44.6M | +13% |
BCG's revenue is growing: $51M last quarter, up 9.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8% | +3.8 points |
| Q2 2026 | 0.9% | +2.3 points |
| Q1 2026 | 5.5% | +2.5 points |
| Q4 2025 | -0.5% | +0.8 points |
| Q3 2025 | 4.2% | +5.7 points |
| Q2 2025 | -1.4% | -0.1 points |
| Q1 2025 | 3% | +6.5 points |
| Q4 2024 | -1.3% | -0.8 points |
BCG's operating margin was 8% last quarter, up 3.8 points from the same quarter a year ago, near the top of its range since 2021.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
BCG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1M | +246% |
| Q2 2026 | $1.1M | +1651% |
| Q1 2026 | $527K | -50% |
| Q4 2025 | $3.1M | +79% |
| Q3 2025 | $884K | +$1.2M |
| Q2 2025 | $63K | -94% |
| Q1 2025 | $1M | +$4.2M |
| Q4 2024 | $1.7M | -36% |
BCG has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BCG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BCG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +2% | +340K shares |
| 3 years | +11% | +1.8M shares |
| 5 years | +19% | +2.7M shares |
BCG has 17M diluted shares, up 2% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | $691 |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $102.9M |
| Q1 2022 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BCG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -3.4x | Net Cash |
| Q1 2025 | -61.3x | Net Cash |
| Q2 2024 | -3.0x | Net Cash |
| Q1 2024 | -0.3x | Net Cash |
BCG has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BCG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 20.7 | Neutral |
BCG's weekly RSI is 37 (neutral) and its Stochastic is 21 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
BCG PE vs Financial Services Sector
| Metric | BCG | Sector median | Relative |
|---|---|---|---|
| PE | 5.3x | 13x | 59% below |
| PE % | 0 | 31 | 31 pts below |
BCG has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BCG has stronger trend alignment. BAC is above 1 of 5 weekly averages versus BCG above 1 of 4.
BCG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.07 | 2.8% above |
| 20 week MA | $1.27 | 13% below |
| 50 week MA | $1.76 | 37% below |
| 100 week MA | $1.94 | 43% below |
BCG has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 43% below its 100-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over BCG on returns for 2026, with the stronger performance.
BCG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $13.0 | $2.90 | -78% |
| 2025 | $2.90 | $2.39 | -18% |
| 2026 YTD | $2.39 | $1.10 | -54% |
BCG has finished every year since 2024 lower, and it's down 54% so far in 2026.